David A. Fox

17.5k total citations · 4 hit papers
230 papers, 13.4k citations indexed

About

David A. Fox is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, David A. Fox has authored 230 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Immunology, 59 papers in Rheumatology and 47 papers in Molecular Biology. Recurrent topics in David A. Fox's work include T-cell and B-cell Immunology (67 papers), Immunotherapy and Immune Responses (40 papers) and Monoclonal and Polyclonal Antibodies Research (39 papers). David A. Fox is often cited by papers focused on T-cell and B-cell Immunology (67 papers), Immunotherapy and Immune Responses (40 papers) and Monoclonal and Polyclonal Antibodies Research (39 papers). David A. Fox collaborates with scholars based in United States, United Kingdom and Japan. David A. Fox's co-authors include Steven K. Lundy, Sujata Sarkar, Laura Tesmer, Ellis L. Reinherz, Stuart F. Schlossman, Judith Endres, Rebecca E. Hussey, Alison M. Gizinski, Oreste Acuto and David H. Katz and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David A. Fox

223 papers receiving 13.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis

2013 1.0k citations Carmelo Carmona‐Rivera, Paul R. Thompson et al. profile →
An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1984 1.0k citations David A. Fox et al. profile →
Th17 cells in human disease

2008 898 citations Steven K. Lundy, Sujata Sarkar et al. profile →
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis

1985 705 citations David A. Fox et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David A. Fox	6.7k	3.3k	3.2k	2.0k	1.6k	230	13.4k
Costantino Pitzalis	6.2k 0.9×	3.3k 1.0×	4.8k 1.5×	2.2k 1.1×	1.3k 0.8×	334	14.2k
Richard M. Pope	5.3k 0.8×	3.9k 1.2×	3.3k 1.0×	2.7k 1.3×	1.2k 0.7×	195	12.2k
Ranjeny Thomas	6.4k 1.0×	2.5k 0.8×	3.1k 1.0×	1.4k 0.7×	1.4k 0.9×	288	13.7k
Alisa E. Koch	4.7k 0.7×	4.9k 1.5×	3.5k 1.1×	3.8k 1.9×	1.1k 0.6×	182	14.1k
Nancy J. Olsen	4.8k 0.7×	2.5k 0.7×	4.5k 1.4×	1.3k 0.6×	1.5k 0.9×	240	12.6k
Fabienne Mackay	13.6k 2.0×	5.1k 1.5×	3.5k 1.1×	2.6k 1.3×	2.4k 1.5×	146	22.2k
G Steiner	3.6k 0.5×	3.9k 1.2×	5.6k 1.7×	2.1k 1.0×	1.7k 1.0×	286	11.7k
David S. Pisetsky	9.0k 1.4×	5.1k 1.5×	4.2k 1.3×	1.3k 0.6×	2.5k 1.5×	356	17.1k
Reinhard Voll	8.0k 1.2×	4.5k 1.3×	3.1k 1.0×	1.6k 0.8×	1000 0.6×	244	13.7k
Keith B. Elkon	10.1k 1.5×	4.7k 1.4×	5.0k 1.6×	1.3k 0.6×	2.2k 1.3×	203	16.4k

Countries citing papers authored by David A. Fox

Since Specialization

Citations

This map shows the geographic impact of David A. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Fox more than expected).

Fields of papers citing papers by David A. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Fox. The network helps show where David A. Fox may publish in the future.

Co-authorship network of co-authors of David A. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Fox. A scholar is included among the top collaborators of David A. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Fox. David A. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fox, David A., et al.. (2025). CD6 in Human Disease. Cells. 14(4). 272–272.

Lin, Feng, et al.. (2025). Ligands of CD6: roles in the pathogenesis and treatment of cancer. Frontiers in Immunology. 15. 1528478–1528478. 1 indexed citations

Wu, Qi, M. Asif Amin, Pei‐Suen Tsou, et al.. (2024). Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells. Cancer Immunology Immunotherapy. 73(2). 34–34. 6 indexed citations

Cooney, Laura A., Qian Xiao, Jason A. Mears, et al.. (2023). 230 Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. Journal of Investigative Dermatology. 143(11). S371–S371. 1 indexed citations

Tebo, Anne E., et al.. (2023). Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency Testing Program. Archives of Pathology & Laboratory Medicine. 148(6). 686–693. 3 indexed citations

Amin, M. Asif, Phillip L. Campbell, Qi Wu, et al.. (2022). Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma. JCI Insight. 7(9). 12 indexed citations

Ruth, Jeffrey H., M. Asif Amin, Phillip L. Campbell, et al.. (2021). CD6 is a target for cancer immunotherapy. JCI Insight. 6(5). 34 indexed citations

O’Neil, Liam J., Ana Barrera‐Vargas, Javier Merayo‐Chalico, et al.. (2020). Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis. Science Advances. 6(44). 81 indexed citations

Zhang, Lingjun, Ping Huang, Thomas L. Saunders, et al.. (2019). Absence of complement component 3 does not prevent classical pathway–mediated hemolysis. Blood Advances. 3(12). 1808–1814. 10 indexed citations

10.

Carmona‐Rivera, Carmelo, Philip M. Carlucci, Erica Moore, et al.. (2017). Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Science Immunology. 2(10). 239 indexed citations

11.

Mao‐Draayer, Yang, Qi Wu, Qin Wang, et al.. (2017). Basic Immunological Profile Changes of SPMS Patients Treated with BAF312 (P1.384). Neurology. 88(16_supplement). 1 indexed citations

12.

Chung, Kevin C., Sandra V. Kotsis, Patricia B. Burns, et al.. (2016). Seven‐Year Outcomes of the Silicone Arthroplasty in Rheumatoid Arthritis Prospective Cohort Study. Arthritis Care & Research. 69(7). 973–981. 21 indexed citations

13.

Dennis, Glynn, Cécile Holweg, Sarah Kummerfeld, et al.. (2014). Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Research & Therapy. 16(2). R90–R90. 265 indexed citations

14.

Tran, Chinh, Steven K. Lundy, & David A. Fox. (2005). Synovial biology and T cells in rheumatoid arthritis. Pathophysiology. 12(3). 183–189. 109 indexed citations

15.

Fox, David A., Sujata Sarkar, S. M. A. Abidi, et al.. (2004). Expression and Characterization of a Novel CD6 Ligand in Cells Derived from Joint and Epithelial Tissues. The Journal of Immunology. 173(10). 6125–6133. 31 indexed citations

16.

Gupta, Raj, Yoshitaka Morita, Xiaogang He, et al.. (2001). Effector Function of Resting T Cells: Activation of Synovial Fibroblasts. The Journal of Immunology. 166(4). 2270–2275. 90 indexed citations

17.

Kozarsky, Karen, et al.. (1995). A Method for Monoclonal Antibody Isotype Switching: Anti-CD60 V _H Expression in a Heavy Chain-Deficient Hybridoma Variant. Hybridoma. 14(6). 597–601. 2 indexed citations

18.

Kozarsky, Karen, et al.. (1988). A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line.. The Journal of Immunology. 140(11). 3758–3765. 55 indexed citations

19.

Boyd, E., Ruth Sanger, M.J.W. Faed, et al.. (1981). Clinical Genetics Society. Abstracts of scientific papers presented on 18 and 19 September 1980 in Aberdeen. Journal of Medical Genetics. 18(3). 218–224. 3 indexed citations

20.

Chiorazzi, Nicholas, David A. Fox, & David H. Katz. (1977). Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 118(1). 48–54. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact